TY - JOUR T1 - The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1186/2051-1426-2-S3-P168 VL - 2 IS - Suppl 3 SP - P168 AU - Maximillian Rosario AU - Bai Liu AU - Lin Kong AU - Stephanie E Schneider AU - Emily K Jeng AU - Peter R Rhode AU - Hing C Wong AU - Todd A Fehniger Y1 - 2014/12/01 UR - http://jitc.bmj.com/content/2/Suppl_3/P168.abstract ER -